Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck - 18 Year Stock Price History | MKKGY

Historical daily share price chart and data for Merck since 2007 adjusted for splits and dividends. The latest closing stock price for Merck as of August 20, 2025 is 26.07.
  • The all-time high Merck stock closing price was 49.25 on December 31, 2021.
  • The Merck 52-week high stock price is 39.17, which is 50.2% above the current share price.
  • The Merck 52-week low stock price is 24.32, which is 6.7% below the current share price.
  • The average Merck stock price for the last 52 weeks is 29.47.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Merck Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 27.1610 28.1665 31.0941 23.9322 26.0700 -7.31%
2024 32.9853 30.1176 38.3544 28.0486 28.1272 -9.01%
2023 33.9983 37.0710 41.5891 28.3653 30.9114 -16.12%
2022 35.5116 47.6908 47.6908 28.8659 36.8513 -25.18%
2021 38.2224 32.9740 49.2506 28.7195 49.2506 53.08%
2020 24.5536 21.9827 32.1737 16.3550 32.1737 46.87%
2019 20.0693 18.7866 22.3645 17.8528 21.9069 15.68%
2018 18.7141 19.5181 20.7026 16.6919 18.9371 -1.98%
2017 20.1355 18.7840 24.2725 18.7273 19.3204 4.57%
2016 17.3304 16.4246 19.7558 14.2301 18.4752 8.35%
2015 17.7528 16.2324 20.4452 15.0669 17.0509 4.51%
2014 15.1092 15.0289 17.4056 13.2248 16.3158 6.05%
2013 13.1882 11.2442 15.3857 10.9329 15.3857 38.42%
2012 9.3049 8.5415 11.6514 7.5966 11.1153 34.60%
2011 7.7824 6.4963 9.4188 6.3062 8.2582 27.60%
2010 6.6931 7.4774 7.7590 5.6797 6.4720 -12.41%
2009 7.3161 7.2088 8.4600 5.5443 7.3888 4.88%
2008 8.9406 10.5838 11.4872 5.5490 7.0447 -26.74%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $16.847B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $71.679B 27.57
Zoetis (ZTS) United States $69.473B 25.20
Daiichi Sankyo, - (DSNKY) Japan $49.821B 25.53
Takeda Pharmaceutical (TAK) Japan $49.256B 10.05
BeOne Medicines - (ONC) Switzerland $33.903B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.730B 0.00
Summit Therapeutics (SMMT) United States $19.217B 0.00
Shionogi (SGIOY) Japan $15.243B 15.27
United Therapeutics (UTHR) United States $13.824B 11.96
Neurocrine Biosciences (NBIX) United States $13.214B 39.42
Orion OYJ (ORINY) Finland $11.248B 27.11
IPSEN (IPSEY) France $11.218B 0.00
Eisai (ESAIY) $9.333B 10.53
Madrigal Pharmaceuticals (MDGL) United States $8.696B 0.00
Corcept Therapeutics (CORT) United States $7.418B 62.30
Grifols, S.A (GRFS) Spain $6.979B 0.00
Stevanato Group S.p.A (STVN) Italy $6.935B 40.89
Ionis Pharmaceuticals (IONS) United States $6.824B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.405B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.355B 18.39
Soleno Therapeutics (SLNO) United States $3.664B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.955B 14.05
Crinetics Pharmaceuticals (CRNX) United States $2.740B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.739B 0.00
Hypermarcas (HYPMY) Brazil $2.689B 20.21
Catalyst Pharmaceuticals (CPRX) United States $2.489B 8.34
Centessa Pharmaceuticals (CNTA) United Kingdom $2.314B 0.00
Ocular Therapeutix (OCUL) United States $2.081B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.759B 0.00
Dyne Therapeutics (DYN) United States $1.703B 0.00
Guardian Pharmacy Services (GRDN) United States $1.649B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.581B 23.55
Ardelyx (ARDX) United States $1.443B 0.00
ARS Pharmaceuticals (SPRY) United States $1.443B 0.00
Harrow (HROW) United States $1.415B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.384B 0.00
Evotec AG (EVO) Germany $1.268B 0.00
Xeris Biopharma Holdings (XERS) United States $1.222B 0.00
Collegium Pharmaceutical (COLL) United States $1.209B 6.60
Enliven Therapeutics (ELVN) United States $1.165B 0.00
Cronos Group (CRON) Canada $0.927B 0.00
Akebia Therapeutics (AKBA) United States $0.827B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.742B 7.65
Amylyx Pharmaceuticals (AMLX) United States $0.716B 0.00
Theravance Biopharma (TBPH) United States $0.674B 55.79
ProKidney (PROK) United States $0.667B 0.00
KalVista Pharmaceuticals (KALV) United States $0.645B 0.00
Siga Technologies (SIGA) United States $0.629B 7.77
Elite Pharmaceuticals (ELTP) United States $0.603B 0.00
Bioventus (BVS) United States $0.596B 14.42
Relay Therapeutics (RLAY) United States $0.586B 0.00
Organogenesis (ORGO) United States $0.581B 0.00
Tourmaline Bio (TRML) United States $0.577B 0.00
USANA Health Sciences (USNA) United States $0.569B 11.65
Oruka Therapeutics (ORKA) United States $0.539B 0.00
Xencor (XNCR) United States $0.536B 0.00
Savara (SVRA) United States $0.534B 0.00
Zevra Therapeutics (ZVRA) United States $0.521B 0.00
Nektar Therapeutics (NKTR) United States $0.513B 0.00
Esperion Therapeutics (ESPR) United States $0.413B 0.00
Nanobiotix S.A (NBTX) France $0.409B 0.00
Aquestive Therapeutics (AQST) United States $0.387B 0.00
Aldeyra Therapeutics (ALDX) United States $0.337B 0.00
Altimmune (ALT) United States $0.320B 0.00
4D Molecular Therapeutics (FDMT) United States $0.320B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.316B 0.00
Larimar Therapeutics (LRMR) United States $0.312B 0.00
Nature's Sunshine Products (NATR) United States $0.291B 18.95
AleAnna (ANNA) United States $0.274B 0.00
Galectin Therapeutics (GALT) United States $0.250B 0.00
OmniAb (OABI) United States $0.225B 0.00
Lyell Immunopharma (LYEL) United States $0.205B 0.00
Heron Therapeutics (HRTX) United States $0.199B 0.00
Aclaris Therapeutics (ACRS) United States $0.196B 0.00
MediWound (MDWD) Israel $0.188B 0.00
China SXT Pharmaceuticals (SXTC) China $0.185B 0.00
Korro Bio (KRRO) United States $0.181B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.178B 27.50
Innate Pharma SA (IPHYF) France $0.173B 0.00
Journey Medical (DERM) United States $0.165B 0.00
Lexeo Therapeutics (LXEO) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.149B 0.00
Profound Medical (PROF) Canada $0.139B 0.00
Achieve Life Sciences (ACHV) Canada $0.132B 0.00
Inhibikase Therapeutics (IKT) United States $0.125B 0.00
Avita Medical (RCEL) United States $0.125B 0.00
Avalo Therapeutics (AVTX) United States $0.121B 0.00
Protara Therapeutics (TARA) United States $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Cassava Sciences (SAVA) United States $0.103B 0.00
Champions Oncology (CSBR) United States $0.101B 22.88
Surrozen (SRZN) United States $0.098B 0.00
Cardiol Therapeutics (CRDL) Canada $0.097B 0.00
ESSA Pharma (EPIX) Canada $0.091B 0.00
Liminatus Pharma (LIMN) United States $0.087B 0.00
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
Dominari Holdings (DOMH) United States $0.086B 0.00
VAXART, INC (VXRT) United States $0.083B 0.00
Context Therapeutics (CNTX) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
Metagenomi (MGX) United States $0.069B 0.00
Nutriband (NTRB) United States $0.069B 0.00
Wellgistics Health (WGRX) United States $0.069B 0.00
Gain Therapeutics (GANX) United States $0.062B 0.00
Prelude Therapeutics (PRLD) United States $0.059B 0.00
DURECT (DRRX) United States $0.059B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Inotiv (NOTV) United States $0.057B 0.00
Karyopharm Therapeutics (KPTI) United States $0.056B 0.00
Jupiter Neurosciences (JUNS) United States $0.056B 0.00
PolyPid (PYPD) Israel $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Unicycive Therapeutics (UNCY) United States $0.052B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.55
Century Therapeutics (IPSC) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
FibroGen (FGEN) United States $0.043B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.034B 0.00
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Vivos Therapeutics (VVOS) United States $0.031B 0.00
Plus Therapeutics (PSTV) United States $0.029B 0.00
CASI Pharmaceuticals (CASI) China $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.025B 0.00
Cosmos Health (COSM) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Scienture Holdings (SCNX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Heatwurx (PCSA) United States $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.01
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
CDT Equity (CDT) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.57
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.55
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00